Latest Breaking News On - Stoke therapeutics company profile - Page 1 : vimarsana.com

Stoke Therapeutics (NASDAQ:STOK) Shares Down 4%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price dropped 4% during mid-day trading on Tuesday . The stock traded as low as $13.75 and last traded at $13.83. Approximately 166,733 shares traded hands during trading, a decline of 82% from the average daily volume of 922,683 shares. The stock had previously closed at […]

United statesJonathan allanCantor fitzgeraldStoke therapeutics incDorsey whitney trustCanaccord genuity groupYork mellon corpJpmorgan chase coSecurities exchange commissionNeedham companyPricet rowe associates incBoard of administration florida retirement systemStoke therapeutics company profileStoke therapeuticsGet free reportGenuity group

Stoke Therapeutics (NASDAQ:STOK) Trading Up 7 2%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price was up 7.2% during trading on Wednesday . The company traded as high as $16.49 and last traded at $16.46. Approximately 277,244 shares changed hands during trading, a decline of 70% from the average daily volume of 932,838 shares. The stock had previously closed at […]

United statesStephenj tulipanoNeedham companyVanguard group incSecurities exchange commissionStoke therapeutics company profileCapital partnersCantor fitzgeraldStoke therapeutics incRedmile groupJpmorgan chase coStoke therapeuticsGet free reportExchange commissionStoke therapeutics daily

Canaccord Genuity Group Lowers Stoke Therapeutics (NASDAQ:STOK) Price Target to $20 00

Canaccord Genuity Group Lowers Stoke Therapeutics (NASDAQ:STOK) Price Target to $20 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan allanBoard of administration florida retirement systemYork mellon corpSherbrooke park advisersStoke therapeutics company profileCanaccord genuity groupDorsey whitney trustStoke therapeutics incJpmorgan chase coNeedham companyStoke therapeuticsFree reportModerate buyTherapeutics stock downGet free report

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc (NASDAQ:STOK)

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc (NASDAQ:STOK)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesSg americas securitiesStoke therapeutics incJpmorgan chase coStoke therapeutics company profileMirae asset global investments coSecurities exchange commissionDorsey whitney trustCanaccord genuity groupNeedham companyYork mellon corpStoke therapeuticsFree reportStoke therapeuticGenuity groupTherapeutics trading down

Stoke Therapeutics, Inc (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0 17 Per Share

Stoke Therapeutics, Inc (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0 17 Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesStephenj tulipanoStoke therapeutics incStoke therapeutics company profileJpmorgan chase coCantor fitzgeraldNeedham companyCanaccord genuity groupCapital partnersMirae asset global investments coSecurities exchange commissionStoke therapeuticsFree reportStoke therapeuticGet free reportTherapeutics stock down